Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of International Oncology
>
2008
>
35
>
10
Volume:
35
Issue:
10
1. Effects of lentiviral-delivered CDC25B2 siRNA on biological behaviors of human pancreatic cancer cell line CFPAC-1
Page:792—797
2. New perspectives on molecular targeted therapy for cancer
Page:750—752
3. Idiotype-pulsed dendritic cells in multiple myeloma immunotherapy
Page:789—792
4. CDX2 gene in development of intestinal type gastric cancer
Page:777—779
5. Assessing tumor vascularity in breast neoplasms by ultrasonography
Page:774—777
6. Development of triple-negative breast cancer
Page:767—771
7. Anti-EGFR strategies for cancer treatment
Page:753—756
8. Research advances of chemokine CCL21
Page:744—747
9. Regulating mechanisms of homeohox gene HOXA7 in tumor genesis and development
Page:741—743
10. Progression of stathmin
Page:738—740
11. Nerve growth factor and its receptors in tumors of nervous system
Page:735—738
12. Research advances in regulation of hypoxia-inducible factor-1 by camptothecin compounds
Page:729—731
13. Transcription factor AP-2 and its effect on cancer
Page:723—726
14. Green tea in chemoprevention of prostate cancer
Page:786—789
15. Relationship between hypoxia reaction and colon carcinoma
Page:783—786
16. RET targeted treatment of medullary thyroid carcinoma
Page:764—767
17. Matrix metalloproteinases and tissue inhibitors of metalloproteinases and their relationship with invasion and metastasis of nasopharyngeal carcinoma
Page:762—764
18. Clinical diagnosis of metastatic cancers of unknown primary site
Page:759—762
19. Application of gene expression profile in tumor radiotherapy
Page:756—758
20. Effect of miRNA on biological characteristics of tumor
Page:747—750
21. Glucosylceramide synthase in tumor multidrug- resistance
Page:732—735
22. Significance of Bcl-2 family in tumor progression and therapy
Page:726—728
23. Study in HGF/c-Met pathway and its association with hepatocellular carcinoma and cholangiocarcinoma
Page:780—783
24. Research of aromatase inhibitor induced osteoporosis
Page:771—774